Accuracy of magnifying endoscopy with methylene blue in the diagnosis of specialized intestinal metaplasia and short-segment Barrett’s esophagus in Japanese patients without Helicobacter pylori infection (2003)

Peer-Reviewed Study · Yagi K; Nakamura A; Sekine A · August 2003

Yagi K et al., 2003-08: Prospective single-centre study in 30 Japanese patients using magnifying endoscopy after methylene blue staining to target biopsies in short-segment columnar-lined oesophagus. Methylene-blue-stained areas had 84.8% sensitivity and 91.7% specificity for specialized intestinal metaplasia.

Specialized intestinal metaplasia was confirmed in biopsy specimens from 28 of the 33 stained areas (sensitivity 84.8%)

Yagi K et al., 2003-08: Prospective single-centre study in 30 Japanese patients using magnifying endoscopy after methylene blue staining to target biopsies in short-segment columnar-lined oesophagus. Methylene-blue-stained areas had 84.8% sensitivity and 91.7% specificity for specialized intestinal metaplasia. Study type: prospective diagnostic accuracy study. N=30 patients, 93 biopsy specimens (33 stained, 60 unstained). Country: Japan. Dose/route: methylene blue staining at endoscopy with magnifying views (concentration in full text); MUC2 immunostaining as reference standard. Comparator: unstained control areas. Funder/conflicts: not stated in abstract. Supports targeted-biopsy detection, though the endpoint is intestinal metaplasia, not cancer. Study type: controlled study.